Potential uses for the epigenetics of aging and why I don’t put much stock in epigenetics-based aging clocks at present
A new trial has reported that the GLP-1 receptor agonist semaglutide reduces risk of cardiovascular events in patients with obesity – but that’s not the question we ought to be asking.
More than “bothersome”: Frequent menopausal hot flashes during sleep are associated with greater white matter hyperintensity volume
Recent pilot research suggests that the psoriasis drug apremilast may have promise in curbing excessive drinking in those with alcohol use disorder.
A recent animal study indicates that the antihypertensive drug rilmenidine has impressive effects on lifespan, but without further evidence, this story seems like another “fountain of youth” myth.